Primary central nervous system lymphomas in immunocompromised patients require specific response criteria.
Schulz N, Nichelli L, Schenone L, Ursu R, Abraham J, Le Cann M, Morel V, Boussen I, Herran D, Leclercq D, Blonski M, Mathon B, Hoang-Xuan K, Soussain C, Choquet S, Houillier C.
Schulz N, et al. Among authors: morel v.
J Neurooncol. 2024 Aug;169(1):51-60. doi: 10.1007/s11060-024-04694-3. Epub 2024 Jun 12.
J Neurooncol. 2024.
PMID: 38865013